Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose

Tweet this page
Registration as it was on 07 Mar 2024
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 01278505562-40


Lobbying Costs

400,000€ - 499,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

3.85 Fte (7)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose   (PPTA Europe aisbl)

    EU Transparency Register

    687559214721-11 First registered on 20 Oct 2014

    Goals / Remit

    As a trusted partner to health systems, PPTA drives broad and reliable access to high-quality plasma protein therapies, with a focus on the well-being of patients and plasma donors. We will strive to achieve our mission by:
    Fostering the collection of high-quality plasma from healthy donors;
    Establishing standards for the manufacturing of lifesaving plasma protein therapies at the highest levels of safety and quality;
    Breaking down artificial barriers on trade and compensated donors that limit patient access to therapy;
    Supporting government reimbursement practices that reflect the unique nature of plasma protein therapies;
    Educating all stakeholders about the value of the therapies; and
    Adhering to the PPTA Code of Ethics.

    Main EU files targeted

    Revision of DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC

    Revision of DIRECTIVE 2004/23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells

    EU Commission Proposal on EU Regulation on Substances of Human Origin, published on 14 July 2022

    EU Commission Evaluation of EU OMP Regulation and Paediatrics Regulation

    Revision of Directive 2001/83/EC Pharmaceuticals legislation - Pharma Code

    EU Pharmaceutical Strategy

    Critical Medicines List


    Head Office
    Boulevard Brand Whitlock, 114/4
    Brussels 1200
    EU Office
    Boulevard Brand Whitlock, 114/4
    Brussels 1200


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    7 accreditations were / are live (in bold) for the selected state of 24 Jul 2024

    Name Start date End Date
    Marilena VRANA 17 Nov 2023 15 Nov 2024
    Halide TUNA 30 Sep 2023 27 Sep 2024
    Rafal RAMOTOWSKI 22 Nov 2023 20 Nov 2024
    Marek KORTUS 09 Nov 2023 08 Nov 2024
    Evelina KOZUBOVSKA 05 Mar 2024 28 Mar 2025
    Alexa WETZEL 15 Sep 2023 13 Sep 2024
    Maarten VAN BAELEN 17 Nov 2023 15 Nov 2024
    Ms Tuna HALIDE 28 Sep 2023 30 Sep 2023
    Evelina KOZUBOVSKA 17 Mar 2023 11 Mar 2024
    Rafal RAMOTOWSKI 06 Dec 2022 22 Nov 2023
    Marilena VRANA 02 Dec 2022 17 Nov 2023
    Maarten VAN BAELEN 28 Sep 2022 28 Sep 2023
    Mr Karl Petrovsky 27 Sep 2022 30 Nov 2022
    Athina Giannoutsou 24 Jun 2022 25 Feb 2023
    Alexa WETZEL 24 Jun 2022 23 Jun 2023
    Evelina KOZUBOVSKA 25 Mar 2022 17 Mar 2023
    Mr Karl Petrovsky 07 Oct 2021 27 Sep 2022
    Athina Giannoutsou 09 Jul 2021 24 Jun 2022
    Alexa WETZEL 09 Jul 2021 24 Jun 2022
    Maarten VAN BAELEN 09 Jul 2021 09 Jul 2022
    Mr Karl Petrovsky 16 Jan 2020 16 Jan 2021
    Mr Karl Petrovsky 23 Jan 2019 16 Jan 2020
    Mr Karl Petrovsky 30 Jan 2018 23 Jan 2019
    Mr Bruno Santoni 23 Jan 2017 20 Jan 2018
    Mr Karl Petrovsky 23 Jan 2017 17 Jan 2018
    Mr Bruno Santoni 02 Feb 2016 19 Jan 2017
    Mr Karl Petrovsky 02 Feb 2016 19 Jan 2017
    Mr Bruno Santoni 13 Feb 2015 02 Feb 2016
    Mr Karl Petrovsky 13 Feb 2015 02 Feb 2016

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Trade and business associations

  • Networking


    EU Health Coalition, Brussels

    Member organisations

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    400,000€ - 499,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    vlahovic group 50,000€ - 99,999€
    bcw 200,000€ - 299,999€

    Intermediaries for current year


    Closed year Costs

    400,000€ - 499,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Communication activities

    Other activities

    None declared

  • Meetings


    4 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 20 Jan 2023 Location Brussels
      Subject EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      • Elina Melngaile (Cabinet member)
      Other Lobbyists
    • Date 17 Mar 2022 Location Bruxelles
      Subject VTC Meeting on Blood, Tissues and Cells legislation and availability of Plasma-Derived Medicinal Products
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      • Karolina Herbout-Borczak (Cabinet member)
      • Ralf Kuhne (Cabinet member)
    • Date 08 Apr 2021 Location online
      Subject Health Union
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      • Margaritis Schinas (Vice-President)
      • Catherine Sustek (Cabinet member)
      Other Lobbyists
    • Date 15 Jun 2018 Location Brussels, Berl
      Subject HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
Download this datacard